Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Kolon Life Science Inc.
DescriptionRecombinant adeno-associated virus (AAV) expressing glutamic acid decarboxylase
Molecular Target
Mechanism of ActionEnzyme replacement therapy; Gene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat cancer pain
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today